GlassScriptPhysician profile
Edgar S Carell
NPI 1174578587
$4,258.84
in general payments reported to CMS, 2019-2025
23 companies · $1,442 in 2025
The $1,442 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $26.13 · 2021: $442 · 2022: $658 · 2023: $604 · 2024: $435 · 2025: $1,442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641 · Travel and Lodging: $840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.88 |
| Travel and Lodging | $839.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,307.43 | 2022-2025 | Varithena Administration Pack, Farapulse, Eluvia |
| Edwards Lifesciences Corporation | $649.74 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Medtronic, INC. | $492.51 | 2021-2025 | Symplicity G3, Hawkone, Onyx Frontier |
| Shockwave Medical, INC | $252.51 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $193.88 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $180.38 | 2019-2024 | Xarelto |
| Cook Medical LLC | $158.85 | 2019-2025 | Rosen, Zilver Ptx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.97 | 2019-2022 | |
| Cardiva Medical, INC. | $146.24 | 2021-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Pfizer INC. | $112.64 | 2019 | |
| Cardiovascular Systems INC. | $101.70 | 2019 | |
| Heartflow, INC. | $100.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $78.78 | 2019-2024 | |
| Philips North America LLC | $71.83 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $55.61 | 2019-2023 | Farxiga |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $51.45 | 2022-2023 | Lifevest |
| Terumo Medical Corporation | $31.34 | 2023 | Optitorque |
| Abbott Laboratories | $24.03 | 2024 | Cardiomems |
| Surmodics, INC. | $23.92 | 2022 | |
| Merck Sharp & Dohme LLC | $19.24 | 2023 | Verquvo |
| Angiodynamics, INC. | $19.13 | 2019 | |
| Teleflex LLC | $17.16 | 2019 | |
| Cardinal Health 200 LLC | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Carell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.